Immunotherapy in which specially modified T cells are used to treat cancer is known as chimeric antigen receptor (CAR) T-cell immunotherapy. In this cell therapy, the patient’s T cells are collected from the blood and then altered to produce specialized chimeric antigen receptors on their surface. When these CAR T cells recover from the patient, […]
